Form S-3 Xeris Biopharma Holdings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Xeris Pharmaceuticals Inc. (XERS) Files $250M Mixed Shelf
March 6, 2025 5:00 PM ESTXeris Pharmaceuticals Inc. (NASDAQ: XERS) has filed $250,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
